59 results
10-K
2021 FY
EX-31.2
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves
10-Q
2021 Q2
EX-31.1
CADL
Candel Therapeutics Inc
8 Sep 21
Quarterly report
8:37am
ability to record, process, summarize and report financial information; and
Any fraud, whether or not material, that involves management or other
10-Q
EX-31.2
8sic458
8 Sep 21
Quarterly report
8:37am